Overview

ToRsemide for pOstpartum HYpertension

Status:
Completed
Trial end date:
2017-09-09
Target enrollment:
Participant gender:
Summary
Currently there is no intervention to prevent persistent postpartum hypertension in preeclamptic women. Physiologically, the use of a pharmacokinetically predictable loop-diuretic is a reasonable intervention to increase elimination of extra fluid accumulated secondary to preeclampsia.The purpose of this study is to assess if Torsemide reduces the incidence of persistent postpartum hypertension in preeclamptic women.
Phase:
Phase 2
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston
Treatments:
Torsemide